Zealand Pharma AS (OCSE:ZEAL)
kr 730 0 (0%) Market Cap: 51.57 Bil Enterprise Value: 43.49 Bil PE Ratio: 0 PB Ratio: 5.83 GF Score: 67/100

Zealand Pharma A/S Corporate Update Call Transcript

Mar 30, 2022 / 02:30PM GMT
Release Date Price: kr107.6 (+11.04%)
Operator

Good morning, everyone, and welcome to the Zealand Pharma's Corporate Update Conference Call. Today's call is being recorded. On the call this morning, we have Martin Nicklasson, Chairman of the Board of Directors; Adam Steensberg, the company's Chief Executive Officer CFO; and Matt Dallas, the company's Chief Financial Officer.

Later in the call, there will be an opportunity to ask a question. Please note that the conference call may contain forward-looking statements and date the conference with regard to the forward-looking statements set out in the accompanying press release issued by Zealand earlier today.

I would now like to start by and the call over to the Chairman of the Board, Martin Nicklasson. Please go ahead.

Alf Gunnar Martin Nicklasson;S;Independent Chairman of the Board
Zealand Pharma A

/-

Thank you, and thank you, everyone, for joining today. Today, we announced several updates, including our reinforced strategy to prioritize research and development and the corporate restructuring to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot